Finance

Beta
Lists
4559:TYO
Zeria Pharmaceutical Co Ltd
¥2,292.00
+0.97%
(+22.00) 1D
May 29, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4559...
Open
¥2,270
High
¥2,292
Low
¥2,267
Mkt. cap
114.87B
Avg. vol.
94.27K
Volume
150.00K
Dividend
2.14%
Quarterly dividend
¥12
Ex-dividend date
Sep 29, 2025
P/E ratio
11.95
52-wk high
¥2,434
52-wk low
¥1,878
EPS
¥192
Shares outstanding
50.11M
No. of employees
2K
Open
¥2,270
High
¥2,292
Low
¥2,267
Mkt. cap
114.87B
Avg. vol.
94.27K
Volume
150.00K
Dividend
2.14%
Quarterly dividend
¥12
Ex-dividend date
Sep 29, 2025
P/E ratio
11.95
52-wk high
¥2,434
52-wk low
¥1,878
EPS
¥192
Shares outstanding
50.11M
No. of employees
2K
News stories
From sources across the web
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG. In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK. In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988. In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries, It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma. The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries. The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees1.75K
FoundedDec 22, 1955
Headquarters-
SectorPharmaceutical industry
Websitezeria.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
19.49B
20.47B
24.12B
25.08B
Cost of goods sold
5.58B
5.59B
6.38B
6.43B
Cost of revenue
5.58B
5.59B
6.38B
6.43B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.39B
12.76B
12.82B
14.84B
Operating expense
12.39B
12.76B
12.82B
14.84B
Total operating expenses
17.97B
18.35B
19.19B
21.27B
Operating income
1.52B
2.12B
4.93B
3.81B
Other non operating income
25.00M
-23.00M
-81.04M
305.04M
EBT including unusual items
1.66B
994.00M
4.63B
3.92B
EBT excluding unusual items
1.66B
994.00M
4.63B
3.76B
Income tax expense
624.00M
383.00M
795.44M
979.56M
Effective tax rate
37.61%
38.53%
-
25.02%
Other operating expenses
-
-
-
-
Net income
1.09B
647.00M
3.82B
2.90B
Net profit margin
5.59%
3.16%
-
11.56%
Earnings per share
-
-
-
-
Interest and investment income
279.00M
30.00M
136.71M
32.29M
Interest expense
-121.00M
-119.00M
-123.00M
-138.00M
Net interest expenses
158.00M
-89.00M
13.71M
-105.71M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.41B
3.88B
6.81B
5.65B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer